Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Feasibility and Efficacy of Autologous Stem Cell Transplantation as First-Line Therapy for Peripheral T-Cell Lymphoma: a Single Center Experience

Lorenzo Falchi, Marco Gunnellini, Monica Schippa, Chiara Listorti, Marta Gubbiotti, Rita Emili, Anna Marina Liberati

Blood (2008) 112 (11): 4441.

https://doi.org/10.1182/blood.V112.11.4441.4441

Published: 2008

Journal Articles

Response to Imatinib or Imatinib Containing Regimens of Secondary Clones in Chronic Myeloid Leukemia Patients with Additional Chromosomal Abnormalities.

Debora Luzi, M.D., Lorenzo Falchi, M.D., Giovanna Rege Cambrin, M.D., Emilia Giugliano, Ph.D., Monica Schippa, M.D., Viola Festuccia, M.D., Ilaria Angeletti, M.D., Emilio Donti, M.D., Anna Marina Liberati, MD

Blood (2007) 110 (11): 4574.

https://doi.org/10.1182/blood.V110.11.4574.4574

Published: 2007

Journal Articles

Persistent Molecular Remission in Patients Treated with Imatinib-IFNa Combination or Imatinib Monotherapy.

Monica Schippa, Enrico Gottardi, Debora Luzi, Lorenzo Falchi, Rita Emili, Ilaria Angeletti, Giorgia Desantis, Erminia Gentileschi, Paola Cerroni, Anna Marina Liberati

Blood (2006) 108 (11): 4784.

https://doi.org/10.1182/blood.V108.11.4784.4784

Published: 2006

Journal Articles

Impact of Complete Kariotypic Remission (CKR) and Sokal Risk on Overall Survival in Chronic Myelogenous Leukemia (CML) Patients: A Monocentric Experience.

Lorenzo Falchi, Monica Schippa, Debora Luzi, Rita Emili, Viola Festuccia, Emilia Giugliano, Carmela Ardisia, Annamaria Rauco, Roberta Pace, Emilio Donti, Anna Marina Liberati

Blood (2006) 108 (11): 4803.

https://doi.org/10.1182/blood.V108.11.4803.4803

Published: 2006

Journal Articles

Molecular Response of CML Patients to INFα Based Treatment or to STI Based Therapy.

Debora Luzi, Rosanna Capozzi, Annamaria Rauco, Roberta Pace, Emilio Donti, Enrico Gottardi, Alessandra Bassetti, Monica Schippa, Giuseppe Saglio, Anna M. Liberati

Blood (2005) 106 (11): 4872.

https://doi.org/10.1182/blood.V106.11.4872.4872

Published: 2005

NARROW

Feasibility and Efficacy of Autologous Stem Cell Transplantation as First-Line Therapy for Peripheral T-Cell Lymphoma: a Single Center Experience

Response to Imatinib or Imatinib Containing Regimens of Secondary Clones in Chronic Myeloid Leukemia Patients with Additional Chromosomal Abnormalities.

Persistent Molecular Remission in Patients Treated with Imatinib-IFNa Combination or Imatinib Monotherapy.

Impact of Complete Kariotypic Remission (CKR) and Sokal Risk on Overall Survival in Chronic Myelogenous Leukemia (CML) Patients: A Monocentric Experience.

Molecular Response of CML Patients to INFα Based Treatment or to STI Based Therapy.

Email alerts

ASH Publications

American Society of Hematology

Feasibility and Efficacy of Autologous Stem Cell Transplantation as First-Line Therapy for Peripheral T-Cell Lymphoma: a Single Center Experience

Response to Imatinib or Imatinib Containing Regimens of Secondary Clones in Chronic Myeloid Leukemia Patients with Additional Chromosomal Abnormalities.

Persistent Molecular Remission in Patients Treated with Imatinib-IFNa Combination or Imatinib Monotherapy.

Impact of Complete Kariotypic Remission (CKR) and Sokal Risk on Overall Survival in Chronic Myelogenous Leukemia (CML) Patients: A Monocentric Experience.

Molecular Response of CML Patients to INFα Based Treatment or to STI Based Therapy.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only